Lipid Droplet Accumulating Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Lipid Droplet-Accumulating Neurons are neurons that accumulate lipid droplets (LDs) in response to various metabolic stresses, mitochondrial dysfunction, and proteostatic challenges. These neurons represent a pathological phenotype observed in multiple neurodegenerative diseases.
Lipid droplets are cytoplasmic organelles that store neutral lipids. While traditionally considered storage organelles in adipocytes and hepatocytes, recent research has revealed their accumulation in neurons under pathological conditions. This accumulation is increasingly recognized as a hallmark of neuronal dysfunction in neurodegeneration.
flowchart TD
A[Mitochondrial Dysfunction] --> B[ATP Depletion] -->
A --> C[ROS Generation] -->
B --> D[Lipogenesis Activation] -->
C --> E[Lipid Peroxidation] -->
D --> F[Fatty Acid Synthesis] -->
E --> G[Lipid Droplet Formation] -->
F --> G
G --> H[LD Accumulation in Neurons] -->
I[ER Stress] --> D
J[Impaired Lipophagy] --> K[LD Clearance Defect] -->
K --> H
- Perilipins (PLINs): Coat LD surface proteins
- DGAT1/2: Acyl-CoA:diacylglycerol acyltransferases
- CPT1/2: Carnitine palmitoyltransferases for fatty acid transport
- ATGL: Adipose triglyceride lipase
- mTOR: Regulates lipophagy
- LD accumulation in hippocampal neurons
- Correlation with Aβ pathology
- Associated with ApoE4 carrier status
- May indicate metabolic dysfunction
- LD accumulation in dopaminergic neurons
- Associated with PINK1/Parkin mutations
- Linked to mitophagy impairment
- Alpha-synuclein colocalization with LDs
- Striatal medium spiny neurons accumulate LDs
- Mutant huntingtin affects lipid metabolism
- May contribute to energy deficit
- Motor neuron LD accumulation
- TDP-43 pathology associated with LDs
- Lipid metabolism dysregulation
- LDs may serve as energy reserve
- Impaired β-oxidation leads to LD accumulation
- Altered NAD+/NADH ratio
- LDs can sequester toxic lipids
- Protect against lipotoxicity
- May represent adaptive response
- LDs can sequester damaged proteins
- Relationship with aggresome formation
- Links to autophagy-lysosome pathway
| Approach |
Mechanism |
Status |
| DGAT1 inhibitors |
Reduce LD formation |
Preclinical |
| CPT1 agonists |
Enhance fatty acid oxidation |
Research |
| mTOR modulators |
Regulate lipophagy |
Experimental |
| Lipophagy inducers |
Enhance LD clearance |
Investigational |
- LD-associated proteins in CSF
- Lipidomic signatures
- Peripheral blood monocyte LD content
- Oil Red O staining
- BODIPY fluorescence
- Electron microscopy
- Super-resolution microscopy
- Lipidomics
- Proteomics of LD fractions
- Western blot for LD proteins
The study of Lipid Droplet Accumulating Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Liu L, et al. (2017). Lipid droplets in neurodegeneration. Biochim Biophys Acta Mol Cell Biol Lipids. 1862(10):1045-1057.
- Ioannou MS, et al. (2019). Neuronal lipid droplets enhance neurodegeneration. Cell. 176(5):1153-1168.
- Moss Wayne, et al. (2020). Lipid droplet accumulation in Alzheimer's disease. Acta Neuropathol. 140(2):177-192.
- Vanhauwaarde R, et al. (2021). Lipid droplets in Parkinson's disease models. Mol Neurodegener. 16(1):45.
- Martinez-Lopez N, et al. (2015). Lipophagy and brain disease. Cell Cycle. 14(10):1503-1512.